Caredx, Inc. (CDNA) SEC Filing 8-K Material Event for the period ending Tuesday, July 31, 2018

Caredx, Inc.

CIK: 1217234 Ticker: CDNA

View differences made from one to another to evaluate Caredx, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Caredx, Inc..


Assess how Caredx, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Caredx, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: CDNA
CIK: 1217234
Form Type: 8-K Corporate News
Accession Number: 0001193125-18-239670
Submitted to the SEC: Mon Aug 06 2018 4:09:05 PM EST
Accepted by the SEC: Mon Aug 06 2018
Period: Tuesday, July 31, 2018
Industry: Medical Laboratories
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: